Overview
The CTS Rotea Counterflow Centrifugation System is a closed, automated cell processing platform designed to streamline cell therapy manufacturing workflows. It enables efficient washing, concentration, buffer exchange, harvesting, and formulation of cells while maintaining high recovery and viability. Built for GMP-compliant environments, the system supports scalable and reproducible processing for cell and gene therapy applications, reducing manual intervention and contamination risk.
Features
• Closed-system automated cell processing for enhanced sterility
• Counterflow centrifugation technology enabling gentle cell handling
• High cell recovery and viability during washing and concentration workflows
• Automated washing, concentration, buffer exchange, and formulation steps
• Compatible with diverse cell types including T cells, stem cells, and PBMCs
• GMP-ready platform supporting translational and clinical manufacturing
• Intuitive software interface with programmable protocols
• Single-use sterile kits minimizing cross-contamination risks
• Scalable workflows from process development to clinical manufacturing
Specifications
• Technology: Counterflow centrifugation-based cell processing
• Processing Functions: Washing, concentration, harvesting, formulation, and buffer exchange
• System Type: Closed automated processing platform
• Disposable Format: Single-use sterile tubing set and processing kits
• Cell Compatibility: T cells, PBMCs, stem cells, NK cells, and other suspension cell types
• Workflow Control: Automated programmable protocols
• Compliance: Designed for GMP and CTS workflow integration
• Connectivity: Data export and process documentation support
• User Interface: Integrated touchscreen control system
Applications
• Cell and gene therapy manufacturing
• T-cell and CAR-T cell processing
• Stem cell washing and concentration
• PBMC isolation and formulation workflows
• Cell harvesting and buffer exchange
• Final formulation prior to cryopreservation or fill-finish
• Clinical and translational research workflows
• GMP-compliant cell therapy production
